This research uncovers how antigenic variation facilitates chronic infection in plasmodium falciparum, suggesting new targets for treatment.
The exceptional virulence of the human malaria parasite, Plasmodium falciparum , is in large part attributed to the adhesive properties of infected red blood cells and the parasite’s ability to avoid antibody recognition through antigenic variation. Both properties are derived from a hypervariable protein placed on the infected cell surface called PfEMP1, different versions of which are encoded by members of the multi-copy var gene family. Over the course of an infection, rising and falling waves of parasitemia correspond to transcriptional switching between var genes, with parasites expressing alternative PfEMP1 isoforms replacing those eliminated by antibodies targeting the previously expressed PfEMP1. var gene expression is controlled epigenetically, however what triggers transcriptional switching and determines which genes are activated is largely unknown. Previous work implicated a unique, universally conserved gene called var2csa as a central component in transcriptional switching, however the molecular basis for its role was obscure. Here we describe how noncoding RNAs, an upstream open reading frame and the nonsense mediated mRNA decay pathway interact to enable var2csa to function as a transiently activated “switching hub” that unifies the var gene family into a single coordinated network, thereby perpetuating chronic infections.
No takes yet. Share an insight, caveat, or question.
Visone et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: